AFCM
ELV icon

Applied Finance Capital Management’s Elevance Health ELV Stock Holding History

Applied Finance Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,964
Closed -$958K – 253
2025
Q3 		$958K Buy
2,964
+208
+8% +$64.7K 0.07% 110
2025
Q2 		$1.07M Sell
2,756
-481
-15% -$193K 0.07% 109
2025
Q1 		$1.41M Buy
+3,237
New +$1.3M 0.1% 83

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Applied Finance Capital Management's ELV Position: Q4 2025 in Review

Applied Finance Capital Management sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 2,964 shares — an estimated $958K sold.

Applied Finance Capital Management first reported a position in ELV in Q1 2025 and held it in 3 quarters. The position peaked at $1.41M in Q1 2025. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Applied Finance Capital Management reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Applied Finance Capital Management sold 2,964 Elevance Health shares in Q4 2025, an estimated $958K.
  • Applied Finance Capital Management first reported a position in Elevance Health in Q1 2025 and held it in 3 quarters.
  • Applied Finance Capital Management's Elevance Health position peaked at $1.41M in Q1 2025.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Applied Finance Capital Management's 13F filing for Q4 2025, filed 5 Feb 2026.